ConductScience.org, home

Paper10071301

Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death.

Dumontet C and 1 other. J Clin Oncol, 1999. Cited by 478 papers, by iCite.

Cite this record

ConductScience Library. Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death. Papers, record 10071301. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10071301

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death.
PubMed
Journal
J Clin Oncol
PubMed
Year
1999
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
478
iCite
Relative citation ratio, by iCite
11.4
iCite
Revised in PubMed
2017-02-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dumontet CC
2Sikic BIB I

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
ApoptosisMajor topic
MicrotubulesMajor topic
Tubulin ModulatorsMajor topic
Amino Acid Sequence
Animals
Binding Sites
Drug Resistance
Humans
Molecular Sequence Data
Paclitaxel
Tubulin
Vinca Alkaloids

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA 52168NCI NIH HHSUnited StatesR01CA052168PubMed and NIHNIH RePORTER
R01 CA 68217NCI NIH HHSUnited StatesR01CA068217PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00222404Pharmacogenomic Study Realized on "Non-small Cell Lung Carcinoma"Background

Source ClinicalTrials.gov

Download CSV of trials

Cited by168

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 478 citations.

PMIDTitleJournalYearIn PapersSource
39941535The Use of Nerve Conduction Study to Evaluate the Effects of Frozen Sock Treatment on Docetaxel-Induced Peripheral Neuropathy in Breast Cancer Patients: A Prospective Clinical Trial.J Clin Med2025https://conductscience.org/library/papers/39941535PubMed
39525629Dopamine internalization via Uptake2 and stimulation of intracellular D5-receptor-dependent calcium mobilization and CDP-diacylglycerol signaling.Front Pharmacol2024https://conductscience.org/library/papers/39525629PubMed
39215442The Role of Tumor Stem Cells in Colorectal Cancer Drug Resistance.Cancer Control2024https://conductscience.org/library/papers/39215442PubMed
39174604Incidence and prognosis of taxane-induced macular edema: a retrospective study from the Japan Clinical REtina Study Group (J-CREST).Sci Rep2024https://conductscience.org/library/papers/39174604PubMed
38934894Cabazitaxel-Loaded Thermosensitive Hydrogel System for Suppressed Orthotopic Colorectal Cancer and Liver Metastasis.Adv Sci (Weinh)2024https://conductscience.org/library/papers/38934894PubMed
38560520Kinesin-7 CENP-E in tumorigenesis: Chromosome instability, spindle assembly checkpoint, and applications.Front Mol Biosci2024https://conductscience.org/library/papers/38560520PubMed
37930483Tyrosine kinase inhibitors (TKIs) for ovarian cancer treatment: from organic to inorganic chemotherapeutics towards selectivity-a perspective overview.Biometals2024https://conductscience.org/library/papers/37930483PubMed
37522022Meibomian gland changes in breast cancer patients treated with docetaxel-partial results.Rom J Ophthalmol2023https://conductscience.org/library/papers/37522022PubMed
37251731Vinca alkaloids as a potential cancer therapeutics: recent update and future challenges.3 Biotech2023https://conductscience.org/library/papers/37251731PubMed
37047597Investigation of the Antineoplastic Effects of 2-(4-Chlorophenyl)-13α-Estrone Sulfamate against the HPV16-Positive Human Invasive Cervical Carcinoma Cell Line SiHa.Int J Mol Sci2023https://conductscience.org/library/papers/37047597PubMed
37047342Involvement of Bcl-2 Family Proteins in Tetraploidization-Related Senescence.Int J Mol Sci2023https://conductscience.org/library/papers/37047342PubMed
35897820Curcumin Induces Apoptosis of Chemoresistant Lung Cancer Cells via ROS-Regulated p38 MAPK Phosphorylation.Int J Mol Sci2022https://conductscience.org/library/papers/35897820PubMed
35660840Cytotoxicity of phenylpironetin analogs and the metabolic fate of pironetin and phenylpironetin.Bioorg Chem2022https://conductscience.org/library/papers/35660840PubMed
351410155-arylalkynyl-2-benzoyl thiophene: a novel microtubule inhibitor exhibits antitumor activity without neurological toxicity.Am J Cancer Res2022https://conductscience.org/library/papers/35141015PubMed
35031699Acquisition of taxane resistance by p53 inactivation in ovarian cancer cells.Acta Pharmacol Sin2022https://conductscience.org/library/papers/35031699PubMed
34995063Inhibition of Microtubule Dynamics in Cancer Cells by Indole-Modified Latonduine Derivatives and Their Metal Complexes.Inorg Chem2022https://conductscience.org/library/papers/34995063PubMed
34626303Development of a proteochemometric-based support vector machine model for predicting bioactive molecules of tubulin receptors.Mol Divers2022https://conductscience.org/library/papers/34626303PubMed
34541464Genomic stability at the coding regions of the multidrug transporter gene ABCB1: insights into the development of alternative drug resistance mechanisms in human leukemia cells.Cancer Drug Resist2020https://conductscience.org/library/papers/34541464PubMed
344855223D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity.Biomed Res Int2021https://conductscience.org/library/papers/34485522PubMed
34423112Thiophene derivative-loaded nanoparticles mediate anticancer activity through the inhibition of kinases and microtubule assembly.Adv Ther (Weinh)2021https://conductscience.org/library/papers/34423112PubMed

See all 168 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PGP283871PubTator's text mininghttps://conductscience.org/library/genes/283871

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10071301

GET https://conductscience.org/api/papers/v1/10071301/cited_by?page=2